MC3 Recorded Education Series: Depression in Youth: Presentation, Diagnosis and Treatment
To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.
Accreditation and Credit Designation
The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Michigan Medical School designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Original Release Date: May 2019
Termination Date: April 2022
Richard Dopp, MD
Richard Dopp, MD
Erin Hughes-Krieger, MSW
Associate Program Manager
Anne Kramer, MSW
There are no relevant financial relationships with ACCME-defined commercial interests to disclose for this activity.
Prevention of Depression in At-Risk Adolescents A Randomized Controlled Trial
Judy Garber, PhD; Gregory N. Clarke, PhD; V. Robin Weersing, PhD; et al. JAMA. 2009;301(21):2215-2224. doi:10.1001/jama.2009.788
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.
David Brent, MD; Graham Emslie, MD; Greg Clarke, PhD; et al. JAMA. 2008 Feb 27;299(8):901-13. doi: 10.1001/jama.299.8.901.
Effective components of TORDIA cognitive-behavioral therapy for adolescent depression: preliminary findings.
Kennard BD1, Clarke GN, Weersing VR, Asarnow JR, Shamseddeen W, Porta G, Berk M, Hughes JL, Spirito A, Emslie GJ, Keller MB, Wagner KD, Brent DA.
J Consult Clin Psychol. 2009 Dec;77(6):1033-41. doi: 10.1037/a0017411.